Looking beyond steroids in professional sports; what are the major drugs, how do they work, and who is using them? Looking at the red blood cell-boosting EPO, HGH, and the future of testing for performance enhancing drugs in sports is your host, Dr. Gary Kohn. Joining him is one of the world's premier authorities on drug testing, Dr. Don Catlin, chief executive of Anti-Doping Research, Inc., in Los Angeles, and the former head of UCLA Olympic Analytical Labs. Dr. Catlin discusses performance enhancing drug use prior to the professional ranks, and a conceptual volunteer program that rewards the non-drug users.
The Future of Performance Enhancing Drugs and Testing
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Looking beyond steroids in professional sports; what are the major drugs, how do they work, and who is using them? Looking at the red blood cell-boosting EPO, HGH, and the future of testing for performance enhancing drugs in sports is your host, Dr. Gary Kohn. Joining him is one of the world's premier authorities on drug testing, Dr. Don Catlin, chief executive of Anti-Doping Research, Inc., in Los Angeles, and the former head of UCLA Olympic Analytical Labs. Dr. Catlin discusses performance enhancing drug use prior to the professional ranks, and a conceptual volunteer program that rewards the non-drug users.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
HF Management for Patients with Comorbid Conditions
0.75 credits
<p>HF Management for Patients with Comorbid Conditions</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
NeuroFrontiers
Navigating Myasthenia Gravis in Adolescents and Young Adults
<p>Navigating Myasthenia Gravis in Adolescents and Young Adults</p>
NeuroFrontiers
Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
<p>Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids</p>
Clinician's Roundtable
Challenges in AI-Driven Dermatology: Understanding Current Limitations
<p>Challenges in AI-Driven Dermatology: Understanding Current Limitations</p>
ACC Action Center
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
<p>Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?